A detailed history of Swiss National Bank transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Swiss National Bank holds 256,600 shares of IONS stock, worth $9.21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
256,600
Previous 258,000 0.54%
Holding current value
$9.21 Million
Previous $12.3 Million 16.4%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$40.06 - $51.86 $56,084 - $72,604
-1,400 Reduced 0.54%
256,600 $10.3 Million
Q2 2024

Aug 08, 2024

BUY
$36.45 - $47.7 $112,995 - $147,870
3,100 Added 1.22%
258,000 $12.3 Million
Q1 2024

May 07, 2024

BUY
$42.03 - $53.55 $25,218 - $32,130
600 Added 0.24%
254,900 $11 Million
Q4 2023

Feb 06, 2024

SELL
$43.39 - $51.63 $1.25 Million - $1.49 Million
-28,800 Reduced 10.17%
254,300 $12.9 Million
Q3 2023

Nov 08, 2023

BUY
$38.5 - $47.13 $115,500 - $141,390
3,000 Added 1.07%
283,100 $12.8 Million
Q2 2023

Aug 09, 2023

BUY
$34.73 - $43.33 $145,866 - $181,986
4,200 Added 1.52%
280,100 $11.5 Million
Q1 2023

May 10, 2023

SELL
$33.58 - $41.2 $1.09 Million - $1.34 Million
-32,500 Reduced 10.54%
275,900 $9.86 Million
Q4 2022

Feb 08, 2023

BUY
$37.12 - $46.52 $215,295 - $269,816
5,800 Added 1.92%
308,400 $11.6 Million
Q3 2022

Nov 09, 2022

BUY
$36.54 - $48.66 $120,582 - $160,578
3,300 Added 1.1%
302,600 $13.4 Million
Q2 2022

Aug 09, 2022

SELL
$31.71 - $43.0 $38,052 - $51,600
-1,200 Reduced 0.4%
299,300 $11.1 Million
Q1 2022

May 09, 2022

BUY
$29.88 - $37.04 $633,456 - $785,248
21,200 Added 7.59%
300,500 $11.1 Million
Q4 2021

Feb 08, 2022

SELL
$25.61 - $35.1 $15,366 - $21,060
-600 Reduced 0.21%
279,300 $8.5 Million
Q2 2021

Aug 06, 2021

SELL
$34.54 - $47.25 $7.96 Million - $10.9 Million
-230,459 Reduced 45.16%
279,900 $11.2 Million
Q1 2021

May 07, 2021

BUY
$42.51 - $63.78 $369,837 - $554,886
8,700 Added 1.73%
510,359 $22.9 Million
Q4 2020

Feb 05, 2021

SELL
$45.3 - $60.27 $625,140 - $831,726
-13,800 Reduced 2.68%
501,659 $28.4 Million
Q3 2020

Nov 09, 2020

SELL
$47.45 - $62.95 $616,850 - $818,350
-13,000 Reduced 2.46%
515,459 $24.5 Million
Q2 2020

Aug 05, 2020

BUY
$46.85 - $61.05 $454,445 - $592,185
9,700 Added 1.87%
528,459 $31.2 Million
Q1 2020

May 08, 2020

BUY
$41.6 - $63.4 $4.07 Million - $6.21 Million
97,900 Added 23.26%
518,759 $24.5 Million
Q4 2019

Feb 06, 2020

SELL
$53.85 - $65.27 $1.04 Million - $1.26 Million
-19,300 Reduced 4.38%
420,859 $25.4 Million
Q3 2019

Nov 12, 2019

BUY
$59.06 - $72.15 $676,768 - $826,766
11,459 Added 2.67%
440,159 $26.4 Million
Q2 2019

Aug 02, 2019

BUY
$62.09 - $86.14 $11.8 Million - $16.4 Million
190,600 Added 80.05%
428,700 $27.6 Million
Q1 2019

May 10, 2019

BUY
$52.92 - $81.17 $396,900 - $608,775
7,500 Added 3.25%
238,100 $19.3 Million
Q4 2018

Feb 13, 2019

BUY
$43.37 - $59.54 $507,428 - $696,618
11,700 Added 5.34%
230,600 $12.5 Million
Q3 2018

Nov 08, 2018

BUY
$42.88 - $53.7 $94,336 - $118,140
2,200 Added 1.02%
218,900 $11.3 Million
Q1 2018

May 04, 2018

BUY
$44.08 - $55.05 $215,992 - $269,745
4,900 Added 2.31%
216,700 $9.55 Million
Q4 2017

Feb 07, 2018

BUY
$50.3 - $64.39 $226,350 - $289,755
4,500 Added 2.17%
211,800 $10.7 Million
Q3 2017

Nov 03, 2017

BUY
$45.56 - $59.57 $9.44 Million - $12.3 Million
207,300
207,300 $10.5 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.1B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.